These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34369899)

  • 21. Procollagen C-proteinase enhancer 1 (PCPE-1) functions as an anti-angiogenic factor and enhances epithelial recovery in injured cornea.
    Massoudi D; Germer CJ; Glisch JM; Greenspan DS
    Cell Tissue Res; 2017 Dec; 370(3):461-476. PubMed ID: 28936615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal Alcohol Exposure Causes Adverse Cardiac Extracellular Matrix Changes and Dysfunction in Neonatal Mice.
    Ninh VK; El Hajj EC; Mouton AJ; Gardner JD
    Cardiovasc Toxicol; 2019 Oct; 19(5):389-400. PubMed ID: 30684169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The globular domain of the proalpha 1(I) N-propeptide is not required for secretion, processing by procollagen N-proteinase, or fibrillogenesis of type I collagen in mice.
    Bornstein P; Walsh V; Tullis J; Stainbrook E; Bateman JF; Hormuzdi SG
    J Biol Chem; 2002 Jan; 277(4):2605-13. PubMed ID: 11705995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
    Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.
    Nagao K; Inada T; Tamura A; Kajitani K; Shimamura K; Yukawa H; Aida K; Sowa N; Nishiga M; Horie T; Makita T; Ono K; Tanaka M
    ESC Heart Fail; 2018 Dec; 5(6):1044-1051. PubMed ID: 30273997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.
    Zile MR; Jhund PS; Baicu CF; Claggett BL; Pieske B; Voors AA; Prescott MF; Shi V; Lefkowitz M; McMurray JJ; Solomon SD;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different patterns of human serum procollagen C-proteinase enhancer1 (PCPE1).
    Mesilaty-Gross S; Anikster Y; Vilensky B; Wolf I; Phillip M; Gat-Yablonski G
    Clin Chim Acta; 2009 May; 403(1-2):76-80. PubMed ID: 19361460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
    Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
    J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
    López B; González A; Lindner D; Westermann D; Ravassa S; Beaumont J; Gallego I; Zudaire A; Brugnolaro C; Querejeta R; Larman M; Tschöpe C; Díez J
    Cardiovasc Res; 2013 Jul; 99(1):111-20. PubMed ID: 23619422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension.
    Cerisano G; Parodi G; Dovellini EV; Migliorini A; Tommasi M; Raspanti S; Buonamici P; Taddeucci E; Valenti R; Antoniucci D
    J Hum Hypertens; 2009 Jan; 23(1):40-7. PubMed ID: 18701924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
    Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
    Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells.
    Tian C; Huang Y; Clauser KR; Rickelt S; Lau AN; Carr SA; Vander Heiden MG; Hynes RO
    Nat Commun; 2021 Apr; 12(1):2328. PubMed ID: 33879793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular fibrogenesis activity assessed by serum levels of procollagen type III N-terminal amino peptide during the staged Fontan procedure.
    Sugimoto M; Saiki H; Tamai A; Seki M; Inuzuka R; Masutani S; Senzaki H
    J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1518-26. PubMed ID: 26926385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency.
    Uusimaa P; Risteli J; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
    Circulation; 1997 Oct; 96(8):2565-72. PubMed ID: 9355895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Processing of procollagen III by meprins: new players in extracellular matrix assembly?
    Kronenberg D; Bruns BC; Moali C; Vadon-Le Goff S; Sterchi EE; Traupe H; Böhm M; Hulmes DJ; Stöcker W; Becker-Pauly C
    J Invest Dermatol; 2010 Dec; 130(12):2727-35. PubMed ID: 20631730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H
    J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC regulates collagen interaction with cardiac fibroblast cell surfaces.
    Harris BS; Zhang Y; Card L; Rivera LB; Brekken RA; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H841-7. PubMed ID: 21666116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.
    Martos R; Baugh J; Ledwidge M; O'Loughlin C; Conlon C; Patle A; Donnelly SC; McDonald K
    Circulation; 2007 Feb; 115(7):888-95. PubMed ID: 17283265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.